-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Eucrates Biomedical Acquisition Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q4 2022.
- Eucrates Biomedical Acquisition Corp. Operating Income (Loss) for the quarter ending December 31, 2022 was -$263K, a 12.7% decline year-over-year.
- Eucrates Biomedical Acquisition Corp. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$699K, a 5.99% increase year-over-year.
- Eucrates Biomedical Acquisition Corp. annual Operating Income (Loss) for 2022 was -$699K, a 5.99% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)